Miracil D: Inhibition of Deoxyribonucleic Acid Polymerase-deficient Escherichia Coli
Overview
Overview
Journal
Antimicrob Agents Chemother
Publisher
American Society for Microbiology
Specialty
Pharmacology
Date
1973 Apr 1
PMID
4597728
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Abstract
Miracil D preferentially inhibited the growth of a deoxyribonucleic acid (DNA) polymerase-deficient Escherichia coli strain. This is taken to indicate that miracil D is capable of altering the DNA of living cells and that it may thereby be a potential mutagen and carcinogen.
References
1.
HIRSCHBERG E, Weinstein I, Gersten N, MARNER E, Finkelstein T, Carchman R
. Structure-activity studies on the mechanism of action of miracil D. Cancer Res. 1968; 28(3):601-7.
View
2.
DE LUCIA P, Cairns J
. Isolation of an E. coli strain with a mutation affecting DNA polymerase. Nature. 1969; 224(5225):1164-6.
DOI: 10.1038/2241164a0.
View
3.
Van Duuren B, Sivak A, Katz C, Melchionne S
. Tumorigenicity of acridine orange. Br J Cancer. 1969; 23(3):587-90.
PMC: 2008414.
DOI: 10.1038/bjc.1969.72.
View
4.
Town C, Smith K, Kaplan H
. DNA polymerase required for rapid repair of x-ray--induced DNA strand breaks in vivo. Science. 1971; 172(3985):851-4.
DOI: 10.1126/science.172.3985.851.
View
5.
Hartman P, Levine K, Hartman Z, Berger H
. Hycanthone: a frameshift mutagen. Science. 1971; 172(3987):1058-60.
DOI: 10.1126/science.172.3987.1058.
View